REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro Terapeutico Integral Del Cauca Ips S.A.S. Cetic Ips (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Other Ambulatory Health Care Services
Full name: Centro Terapeutico Integral Del Cauca Ips S.A.S. Cetic Ips Profile Updated: February 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Centro Terapeutico Integral Del Cauca Ips S.A.S. Cetic Ips is an enterprise in Colombia, with the main office in Popayan. It operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on November 20, 2009. The latest financial highlights indicate a net sales revenue increase of 6.8% in 2025. Its’ total assets recorded a negative growth of 11%. The net profit margin of Centro Terapeutico Integral Del Cauca Ips S.A.S. Cetic Ips increased by 3.78% in 2025.

Headquarters
Cr 13 Nro. 7 - 22
Popayan; Cauca;

Contact Details: Purchase the Centro Terapeutico Integral Del Cauca Ips S.A.S. Cetic Ips report to view the information.

Basic Information
Registered Capital:
Purchase the Centro Terapeutico Integral Del Cauca Ips S.A.S. Cetic Ips report to view the information.
Financial Auditors:
Purchase the Centro Terapeutico Integral Del Cauca Ips S.A.S. Cetic Ips report to view the information.
Incorporation Date:
November 20, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro Terapeutico Integral Del Cauca Ips S.A.S. Cetic Ips report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
6.8%
Total Operating Revenue
6.8%
Operating Profit
31.75%
EBITDA
20.38%
Net Profit/Loss for the Period
56.31%
Total Assets
-11%
Total Equity
387.25%
Operating Profit Margin
2.69%
Net Profit Margin
3.78%
Return on Equity (ROE)
-168.26%
Quick Ratio
1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?